Evidence map›Paper›PMID 39737004›Full record

ArticleFrontiers in genetics2024

Novel variant alters splicing of

Emily R Gordon, Stephanie A Felker, Tanner F Coleman, Nadiya Sosonkina, Jada Pugh, Meagan E Cochran, Anna C E Hurst, Sara J Cooper

Abstract read
In one paragraph

Article in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Case report: Loeys-Dietz syndrome (European heart journal. Case reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emily R GordonHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.
Stephanie A FelkerHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.
Tanner F ColemanHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.
Nadiya SosonkinaMolecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
Jada PughHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.
Meagan E CochranHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.
Anna C E HurstDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States.
Sara J CooperHudsonAlpha Institute for Biotechnology, Huntsville, AL, United States.

Funding

UAB-HudsonAlpha Genomic Medicine Training ProgramT32HG008961 · NHGRI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Gregory Michael Cooper, Marguerite R Irvin · 2016 to 2026
$2.5M
NHGRI NIH HHS T32 HG008961
6 · The paper itself

Abstract

Loeys-Dietz syndrome (LDS) is a connective tissue disorder representing a wide spectrum of phenotypes, ranging from isolated thoracic aortic aneurysm or dissection to a more severe syndromic presentation with multisystemic involvement. Significant clinical variability has been noted for both related and unrelated individuals with the same pathogenic variant. We report a family of five affected individuals with notable phenotypic variability who appear to have two distinct molecular causes of LDS, one attributable to a missense variant in

Indexed as

clinical genomicsconnective tissue disorderLoeys-Dietznoncoding variationSpliceAIsplicingTGFB2WGS

Identifiers

PMID39737004
PMCPMC11683094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.